Trial intelligence / Profile preview

Propofol versus dexmedetomidine for sedation during IVF

IRCT20190121042444N2Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of propofol and dexmedetomidine in infertility (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Fertility rate and Best drug with appropriate outcomes in women undergoing IVF treatment. Started Mar 2020; status: completed.

02

Drugs

propofoldexmedetomidine
03

Conditions

infertility

Beyond the preview

Go deeper on IRCT20190121042444N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190121042444N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call